BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26418278)

  • 21. Computational explanation for bioactivation mechanism of targeted anticancer agents mediated by cytochrome P450s: A case of Erlotinib.
    Ai CZ; Liu Y; Li W; Chen DM; Zhu XX; Yan YW; Chen DC; Jiang YZ
    PLoS One; 2017; 12(6):e0179333. PubMed ID: 28628631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CYP P450 arachidonic acid monooxygenases: from cell signaling to blood pressure regulation.
    Capdevila JH; Falck JR
    Biochem Biophys Res Commun; 2001 Jul; 285(3):571-6. PubMed ID: 11453630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro biotransformation and identification of human cytochrome P450 isozyme-dependent metabolism of tazofelone.
    Surapaneni SS; Clay MP; Spangle LA; Paschal JW; Lindstrom TD
    Drug Metab Dispos; 1997 Dec; 25(12):1383-8. PubMed ID: 9394028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First evidence that cytochrome P450 may catalyze both S-oxidation and epoxidation of thiophene derivatives.
    Dansette PM; Bertho G; Mansuy D
    Biochem Biophys Res Commun; 2005 Dec; 338(1):450-5. PubMed ID: 16137656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of glutathione conjugates derived from reactive metabolites of bakuchiol.
    Chi M; Peng Y; Zheng J
    Chem Biol Interact; 2016 Jan; 244():178-86. PubMed ID: 26712081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.
    Pirmohamed M; Madden S; Park BK
    Clin Pharmacokinet; 1996 Sep; 31(3):215-30. PubMed ID: 8877251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Covalent thiol adducts arising from reactive intermediates of cocaine biotransformation.
    Schneider KJ; DeCaprio AP
    Chem Res Toxicol; 2013 Nov; 26(11):1755-64. PubMed ID: 24112049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biologically-active and chemically-reactive polycyclic hydrocarbon metabolites.
    Phillips DH; Grover PL
    IARC Sci Publ; 1984; (59):47-61. PubMed ID: 6545297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling the Bioactivation and Subsequent Reactivity of Drugs.
    Hughes TB; Flynn N; Dang NL; Swamidass SJ
    Chem Res Toxicol; 2021 Feb; 34(2):584-600. PubMed ID: 33496184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in predicted chemoselectivity of cytochrome P450 oxidation: B3LYP barrier heights for epoxidation and hydroxylation reactions.
    Rydberg P; Lonsdale R; Harvey JN; Mulholland AJ; Olsen L
    J Mol Graph Model; 2014 Jul; 52():30-5. PubMed ID: 25000094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Streptomyces cytochromes P450: applications in drug metabolism.
    Lamb DC; Waterman MR; Zhao B
    Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1279-94. PubMed ID: 23738914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Theoretical insights into the reductive metabolism of CCl4 by cytochrome P450 enzymes and the CCl4-dependent suicidal inactivation of P450.
    Li XX; Zheng QC; Wang Y; Zhang HX
    Dalton Trans; 2014 Oct; 43(39):14833-40. PubMed ID: 25164482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification.
    Iyanagi T
    Int Rev Cytol; 2007; 260():35-112. PubMed ID: 17482904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytochromes P450: Role in Carcinogenesis and Relevance to Cancers.
    Abu-Bakar A; Tan BH; Halim H; Ramli S; Pan Y; Ong CE
    Curr Drug Metab; 2022 Aug; 23(5):355-373. PubMed ID: 35345986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fast prediction of cytochrome P450 mediated drug metabolism.
    Rydberg P; Vasanthanathan P; Oostenbrink C; Olsen L
    ChemMedChem; 2009 Dec; 4(12):2070-9. PubMed ID: 19852016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational toxicological investigation on the mechanism and pathways of xenobiotics metabolized by cytochrome P450: a case of BDE-47.
    Wang X; Wang Y; Chen J; Ma Y; Zhou J; Fu Z
    Environ Sci Technol; 2012 May; 46(9):5126-33. PubMed ID: 22471442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of new flavone-8-acetic acid metabolites using mouse microsomes and comparison with human microsomes.
    Pham MH; Auzeil N; Regazzetti A; Dauzonne D; Dugay A; Menet MC; Scherman D; Chabot GG
    Drug Metab Dispos; 2007 Nov; 35(11):2023-34. PubMed ID: 17664249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct Observation of an Oxepin from a Bacterial Cytochrome P450-Catalyzed Oxidation.
    Stok JE; Chow S; Krenske EH; Farfan Soto C; Matyas C; Poirier RA; Williams CM; De Voss JJ
    Chemistry; 2016 Mar; 22(13):4408-12. PubMed ID: 26811874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
    Avent KM; DeVoss JJ; Gillam EM
    Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytochrome P-450-dependent bioactivation of 1,1-dichloroethylene to a reactive epoxide in human lung and liver microsomes.
    Dowsley TF; Reid K; Petsikas D; Ulreich JB; Fisher RL; Forkert PG
    J Pharmacol Exp Ther; 1999 May; 289(2):641-8. PubMed ID: 10215634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.